
Pliant Therapeutics Inc (PLRX) with a beta value of 1.43 appears to be a promising investment opportunity.
A new trading day began on Tuesday, with Pliant Therapeutics Inc (NASDAQ: PLRX) stock price down -6.37% from the previous day of trading, before settling